Quick Answer
NICE Ltd. reported Cash and Equivalents of $379.39 million for fiscal year 2025.
NICE Ltd. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $379.39M | -21.2% |
| 2024 | $481.71M | -5.9% |
| 2023 | $511.80M | -3.4% |
| 2022 | $529.60M | +39.9% |
| 2021 | $378.66M | -14.4% |
| 2020 | $442.27M | +93.7% |
| 2019 | $228.32M | -5.7% |
| 2018 | $242.10M | -26.3% |
| 2017 | $328.30M | +109.1% |
| 2016 | $157.03M | -51.8% |
| 2015 | $325.93M | +73.8% |
| 2014 | $187.50M | +56.8% |
| 2013 | $119.55M | +21.2% |
| 2012 | $98.60M | -51.8% |
| 2011 | $204.44M | +86.7% |
| 2010 | $109.53M | -49.0% |
| 2009 | $214.81M | +48.8% |
| 2008 | $144.38M | +23.8% |
| 2007 | $116.62M | — |
- NICE Ltd. showed a decrease of -21.2% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2007–2025 period, NICE Ltd.’s cash and equivalents has grown by 225.3% (from $116.62 million to $379.39 million).
- The most recent figure is from NICE Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: